Skip to main content
Erschienen in: European Radiology 8/2014

01.08.2014 | Oncology

Thermal ablation techniques: a curative treatment of bone metastases in selected patients?

verfasst von: F. Deschamps, G. Farouil, N. Ternes, A. Gaudin, A. Hakime, L. Tselikas, C. Teriitehau, E. Baudin, A. Auperin, T. de Baere

Erschienen in: European Radiology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Thermal ablation techniques (radiofrequency-ablation/cryotherapy) can be indicated with a curative intent. The success rate and prognostic factors for complete treatment were analysed.

Material/methods

The medical records of all patients who had undergone curatively intended thermal ablation of bone metastases between September 2001 and February 2012 were retrospectively analysed. The goal was to achieve complete treatment of all bone metastases in patients with oligometastatic disease (group 1) or only of bone metastases that could potentially lead to skeletal-related events in patients with a long life expectancy (group 2). We report the rate of complete treatment according to patient characteristics, primary tumour site, bone metastasis characteristics, radiofrequency ablation/cryotherapy and the treatment group (group 1/group 2).

Results

Eighty-nine consecutive patients had undergone curatively intended thermal ablation of 122 bone metastases. The median follow-up was 22.8 months [IQR = 12.2-44.4]. In the intent-to-treat analysis, the 1-year complete treatment rate was 67 % (95%CI: 50 %-76 %). In the multivariate analysis the favourable prognostic factors for complete local treatment were oligometastatic status (p = 0.02), metachronous (p = 0.004) and small-sized (p = 0.001) bone metastases, without cortical bone erosion (p = 0.01) or neurological structures in the vicinity (p = 0.002).

Conclusion

Thermal ablation should be included in the therapeutic arsenal for the cure of bone metastases.

Key Points

Thermal ablation techniques are currently performed to palliate pain caused by bone metastases.
In selected patients, thermal ablation can also be indicated with a curative intent.
Oligometastatic and/or metachronous diseases are good prognostic factors for local success.
Small-size (<2 cm) bone metastases and no cortical erosion are good prognostic factors.
Literatur
1.
Zurück zum Zitat Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef
2.
Zurück zum Zitat Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249sPubMedCrossRef Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249sPubMedCrossRef
3.
Zurück zum Zitat Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10PubMed Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10PubMed
4.
Zurück zum Zitat Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8:378–382PubMed Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8:378–382PubMed
5.
Zurück zum Zitat Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–773PubMedCrossRef Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–773PubMedCrossRef
6.
Zurück zum Zitat Mayo SC, Pawlik TM (2010) Thermal ablative therapies for secondary hepatic malignancies. Cancer J 16:111–117PubMedCrossRef Mayo SC, Pawlik TM (2010) Thermal ablative therapies for secondary hepatic malignancies. Cancer J 16:111–117PubMedCrossRef
7.
Zurück zum Zitat Thumar AB, Trabulsi EJ, Lallas CD, Brown DB (2010) Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up. J Vasc Interv Radiol 21:S233–S241PubMedCrossRef Thumar AB, Trabulsi EJ, Lallas CD, Brown DB (2010) Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up. J Vasc Interv Radiol 21:S233–S241PubMedCrossRef
8.
Zurück zum Zitat Feng B, Liang P (2012) Local thermal ablation of renal cell carcinoma. Eur J Radiol 81:437–440PubMedCrossRef Feng B, Liang P (2012) Local thermal ablation of renal cell carcinoma. Eur J Radiol 81:437–440PubMedCrossRef
9.
Zurück zum Zitat de Baere T (2011) Lung tumour radiofrequency ablation: where do we stand? Cardiovasc Intervent Radiol 34:241–251PubMedCrossRef de Baere T (2011) Lung tumour radiofrequency ablation: where do we stand? Cardiovasc Intervent Radiol 34:241–251PubMedCrossRef
10.
11.
Zurück zum Zitat Gangi A, Alizadeh H, Wong L, Buy X, Dietemann JL, Roy C (2007) Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients. Radiology 242:293–301PubMedCrossRef Gangi A, Alizadeh H, Wong L, Buy X, Dietemann JL, Roy C (2007) Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients. Radiology 242:293–301PubMedCrossRef
12.
Zurück zum Zitat Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW, Menendez L (2009) Thermal ablation of osteoid osteoma: overview and step-by-step guide. Radiographics 29:2127–2141PubMedCrossRef Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW, Menendez L (2009) Thermal ablation of osteoid osteoma: overview and step-by-step guide. Radiographics 29:2127–2141PubMedCrossRef
13.
Zurück zum Zitat Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Grönemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306PubMedCrossRef Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Grönemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306PubMedCrossRef
14.
Zurück zum Zitat Rosenthal D, Callstrom MR (2012) Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology 262:765–780PubMedCrossRef Rosenthal D, Callstrom MR (2012) Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology 262:765–780PubMedCrossRef
15.
Zurück zum Zitat Munk PL, Murphy KJ, Gangi A, Liu DM (2011) Fire and ice: percutaneous ablative therapies and cement injection in management of metastatic disease of the spine. Semin Musculoskelet Radiol 15:125–134PubMedCrossRef Munk PL, Murphy KJ, Gangi A, Liu DM (2011) Fire and ice: percutaneous ablative therapies and cement injection in management of metastatic disease of the spine. Semin Musculoskelet Radiol 15:125–134PubMedCrossRef
16.
Zurück zum Zitat Kurup AN, Callstrom MR (2010) Ablation of skeletal metastases: current status. J Vasc Interv Radiol 21:S242–S250PubMedCrossRef Kurup AN, Callstrom MR (2010) Ablation of skeletal metastases: current status. J Vasc Interv Radiol 21:S242–S250PubMedCrossRef
17.
Zurück zum Zitat Rothman KJ (1978) Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis 31:557–560PubMedCrossRef Rothman KJ (1978) Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis 31:557–560PubMedCrossRef
18.
Zurück zum Zitat Lo SS, Moffatt-Bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman R (2011) The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 8:405–416PubMedCrossRef Lo SS, Moffatt-Bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman R (2011) The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 8:405–416PubMedCrossRef
19.
Zurück zum Zitat Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, Villaflor VM, Stadler WM, Hoffman PC, Cohen EE, Connell PP, Haraf DJ, Vokes EE, Hellman S, Weichselbaum RR (2012) Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 118:2962–2970PubMedCrossRef Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, Villaflor VM, Stadler WM, Hoffman PC, Cohen EE, Connell PP, Haraf DJ, Vokes EE, Hellman S, Weichselbaum RR (2012) Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 118:2962–2970PubMedCrossRef
20.
Zurück zum Zitat Fumagalli I, Bibault JE, Dewas S, Kramar A, Mirabel X, Prevost B, Lacornerie T, Jerraya H, Lartigau E (2012) A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol 7:164PubMedCentralPubMedCrossRef Fumagalli I, Bibault JE, Dewas S, Kramar A, Mirabel X, Prevost B, Lacornerie T, Jerraya H, Lartigau E (2012) A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol 7:164PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat De Ruysscher D, Wanders R, van Baardwijk A, Dingemans AM, Reymen B, Houben R, Bootsma G, Pitz C, van Eijsden L, Geraedts W, Baumert BG, Lambin P (2012) Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 7:1547–1555PubMedCrossRef De Ruysscher D, Wanders R, van Baardwijk A, Dingemans AM, Reymen B, Houben R, Bootsma G, Pitz C, van Eijsden L, Geraedts W, Baumert BG, Lambin P (2012) Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 7:1547–1555PubMedCrossRef
22.
Zurück zum Zitat Onaitis MW, Petersen RP, Haney JC, Saltz L, Park B, Flores R, Rizk N, Bains MS, Dycoco J, D'Amico TA, Harpole DH, Kemeny N, Rusch VW, Downey R (2009) Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 87:1684–1688PubMedCrossRef Onaitis MW, Petersen RP, Haney JC, Saltz L, Park B, Flores R, Rizk N, Bains MS, Dycoco J, D'Amico TA, Harpole DH, Kemeny N, Rusch VW, Downey R (2009) Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 87:1684–1688PubMedCrossRef
23.
Zurück zum Zitat Hornbech K, Ravn J, Steinbruchel DA (2011) Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002-2006. J Thorac Oncol 6:1733–1740PubMedCrossRef Hornbech K, Ravn J, Steinbruchel DA (2011) Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002-2006. J Thorac Oncol 6:1733–1740PubMedCrossRef
24.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCentralPubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Orita Y, Sugitani I, Matsuura M, Ushijima M, Tsukahara K, Fujimoto Y, Kawabata K (2010) Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147:424–431PubMedCrossRef Orita Y, Sugitani I, Matsuura M, Ushijima M, Tsukahara K, Fujimoto Y, Kawabata K (2010) Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147:424–431PubMedCrossRef
26.
Zurück zum Zitat Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83:878–886PubMedCrossRef Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83:878–886PubMedCrossRef
27.
Zurück zum Zitat Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR (2012) Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol 2:215PubMedCentralPubMedCrossRef Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR (2012) Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol 2:215PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573PubMedCrossRef Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573PubMedCrossRef
29.
Zurück zum Zitat Woodward E, Jagdev S, McParland L, Clark K, Gregory W, Newsham A, Rogerson S, Hayward K, Selby P, Brown J (2011) Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48:160–166PubMedCrossRef Woodward E, Jagdev S, McParland L, Clark K, Gregory W, Newsham A, Rogerson S, Hayward K, Selby P, Brown J (2011) Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48:160–166PubMedCrossRef
30.
Zurück zum Zitat Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C (2013) Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab 98:1492–1497PubMedCrossRef Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C (2013) Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab 98:1492–1497PubMedCrossRef
31.
Zurück zum Zitat McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, Atwell TD, Schmit GD, Morris JM, Woodrum DA, Weisbrod AJ, Rose PS, Callstrom MR (2013) Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 24:207–213PubMedCrossRef McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, Atwell TD, Schmit GD, Morris JM, Woodrum DA, Weisbrod AJ, Rose PS, Callstrom MR (2013) Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 24:207–213PubMedCrossRef
Metadaten
Titel
Thermal ablation techniques: a curative treatment of bone metastases in selected patients?
verfasst von
F. Deschamps
G. Farouil
N. Ternes
A. Gaudin
A. Hakime
L. Tselikas
C. Teriitehau
E. Baudin
A. Auperin
T. de Baere
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3202-1

Weitere Artikel der Ausgabe 8/2014

European Radiology 8/2014 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.